uploads/2018/11/ILMN2.png

Understanding Illumina’s Geographical Performance

By

Updated

Geographical performance

Illumina (ILMN) generates revenue from the Americas, the EMEA (Europe, the Middle East, and Africa) region, Greater China, and the Asia-Pacific region. Its revenue from the Americas increased from $417.0 million in the third quarter of 2017 to $474.0 million in the third quarter of 2018. Its revenue in the EMEA region rose from $165.0 million in the third quarter of 2017 to $219.0 million in the third quarter of 2018.

Illumina’s revenue in Greater China surged from $87.0 million in the third quarter of 2017 to $102.0 million in the third quarter of 2018. Its Asia-Pacific revenue increased from $45.0 million in the third quarter of 2017 to $58.0 million in the third quarter of 2018.

Article continues below advertisement

Revenue forecast

For 2018 and 2019, Illumina is expected to generate revenues of $3.33 billion and $3.80 billion, respectively, compared to revenue of $2.75 billion in 2017.

In comparison, the 2018 revenues of peers Danaher (DHR), Thermo Fisher Scientific (TMO), and Waters Corporation (WAT) are expected to be $19.84 billion, $24.08 billion, and $2.41 billion, respectively.

Illumina’s cash per share stands at $23.10. In comparison, Danaher, Thermo Fisher Scientific, and Waters have cash per share of $1.10, $2.77, and $27.64, respectively.

We’ll take a look at Illumina’s gross margin trend in the next article.

Advertisement

More From Market Realist